ライフサイエンスコーパス: catheter

1 inder) of the left and right atria (PentaRay catheter).

2 and ABP was monitored via a femoral arterial catheter.

3 F temporary drainage/externalized peritoneal catheter.

4 in) using a left ventricular pressure/volume catheter.

5 constructed based on a 40 MHz clinical IVUS catheter.

6 mapped in both atria with a 20-pole PentaRay catheter.

7 ilaterally using the St Jude EnligHTN basket catheter.

8 76) of pleural fluid via a tunneled pleural catheter.

9 t PV isolation with a standard force-sensing catheter.

10 over 3.5 cm with an irrigated radiofrequency catheter.

11 ing ThermoCool SmartTouch (Biosense Webster) catheter.

12 opleurodesis and faster time to liberty from catheter.

13 C57BL/6 mice and in vitro cell catheters.

14 ith M. bovis-BCG in patients with indwelling catheters.

15 cessary use of intravenous and urinary tract catheters.

16 the teaching and prescribing of intermittent catheters.

17 ubclavian or internal jugular central venous catheters.

18 wing the placement of the indwelling pleural catheters.

19 re-use were most resistant to the re-use of catheters.

20 All had permanent central venous catheters.

21 se members saw patients who use intermittent catheters.

22 an be utilized as an alternative coating for catheters.

23 tes, between those using single or multi-use catheters.

24 11+/-0.004 mV, lower than that of a standard catheter (0.016+/-0.019) and surface ECG (0.02+/-0.01; P

25 n results (64.5% vs 44.4%; P = .03), femoral catheters (16.1% vs 5.5%; P = .02), repair and/or ligati

26 The most common sources were central venous catheters (41%) and pneumonia (20%).

27 (39.8%) and the presence of a central venous catheter (50.9%) or tracheostomy (64.8%).

28 n results (49.3% vs 35.7%; P = .02), femoral catheters (9.6% vs 3.9%; P = .03), repair and/or ligatio

29 We evaluated 18,554 central venous catheters: 9,331 from observational studies, 5,482 from

30 Catheter ablation (CA) for atrial fibrillation (AF) has

31 brillation (VLRAF) occuring >12 months after catheter ablation (CA) in apparently "cured" patients co

32 amiodarone [n=103] or sotalol [n=78]) and AF catheter ablation (n=49) or the Maze procedure at surgic

33 Clinical Question: Is catheter ablation better than antiarrhythmic drugs for t

34 ting >30 seconds, determined 3 months beyond catheter ablation by a blinded end-point evaluation.

35 elevated risk for sudden cardiac death, and catheter ablation can be used as adjunctive therapy to t

36 Safe and successful radiofrequency catheter ablation depends on creation of transmural lesi

37 However, catheter ablation did reduce the total number of ICD int

38 ot reduce atrial arrhythmia recurrence after catheter ablation for AF but resulted in more hypotensio

39 Radiofrequency catheter ablation for atrial fibrillation has become an

40 between the study arms significantly favored catheter ablation for both the primary end point and all

41 Radiofrequency catheter ablation has become the treatment strategy of c

42 We analyzed results of radiofrequency catheter ablation in a large cohort of patients with CHD

43 mic drug therapy, electric cardioversion, or catheter ablation in comparison with men.

44 art disease and discuss the evolving role of catheter ablation in decreasing ventricular arrhythmia r

45 nts recurrent atrial fibrillation (AF) after catheter ablation in patients with AF and a high symptom

46 nital heart disease (CHD) and the outcome of catheter ablation in this population have not been studi

47 Catheter ablation is an increasingly utilized treatment

48 In these patients, catheter ablation is considered for symptom management o

49 This study demonstrates that the outcome of catheter ablation is favorable in patients with simple C

50 Its use during radiofrequency catheter ablation may allow the operator to assess the d

51 In these individuals, catheter ablation may be used as adjunctive therapy to t

52 ctroporation seems to be a safe modality for catheter ablation near the esophagus.

53 Catheter ablation of atrial fibrillation is associated w

54 n anatomic obstacles preclude radiofrequency catheter ablation of idiopathic ventricular arrhythmias

55 Catheter ablation of ventricular tachycardia (VT) is bei

56 oke reduction benefit of rhythm control with catheter ablation over a rate control strategy.

57 studies have demonstrated the superiority of catheter ablation over pharmacological therapy for maint

58 fibrillation undergoing PVI from the Swedish Catheter Ablation Register were included, with informati

59 patient-years) with 81% off anticoagulation, catheter ablation reinterventions in 13 patients for atr

60 Catheter ablation resulted in complete procedural succes

61 When a standard catheter ablation targeting the best electrophysiologica

62 Specifically, the advances in catheter ablation technology and strategies have not tra

63 Catheter ablation therapy, commonly used in the treatmen

64 ofrequency instruments, required endocardial catheter ablation to complete the linear ablation lesion

65 The initial 57 patients (group A) underwent catheter ablation using a novel superolateral MIL design

66 (Catheter Ablation Versus Medical Rate Control in Atrial

67 Bottom Line: Radiofrequency catheter ablation was found to be superior to antiarrhyt

68 Catheter ablation was successful in 10 patients, and VAs

69 l tachyarrhythmias undergoing radiofrequency catheter ablation were classified according to complexit

70 Catheter ablation with substrate modification is effecti

71 During the catheter ablation, a mean number of 10.4+/-7.4 radiofreq

72 h more costly inpatient therapies such as AF catheter ablation, but this finding was associated with

73 a structurally normal heart and the role of catheter ablation.

74 0 mm Hg) treatment before their scheduled AF catheter ablation.

75 reentrant tachycardia and were treated with catheter ablation.

76 ignificant subgroup of patients referred for catheter ablation.

77 obotics, with applications such as steerable catheters, adaptive wings for aircraft and drag-reducing

78 hemodialysis with a fistula placed first, a catheter after a fistula placed first failed, or a cathe

79 er, the group initiating hemodialysis with a catheter after failed fistula placement also had signifi

80 fistula, and 8230 initiated dialysis with a catheter after failed fistula placement.

81 high inflammation levels at the site of the catheter after infection.

82 ugh the arteries, which was decreased in the catheter after infection.

83 cultures were collected from central venous catheters after vs before the intervention (389 [39.5%]

84 measured simultaneously by pulmonary artery catheter and aortic transpulmonary thermodilution on 92

85 e (BP) was directly measured by the arterial catheter and found 13.8% higher in HS vs Cont rats.

86 prespecified sites, as well as on a standard catheter and on the surface ECG.

87 ep were catheterized with aortic and femoral catheters and a flow transducer around the external ilia

88 ovascular interventions involving large-bore catheters and its association with in-hospital mortality

89 cause of the increased use of central venous catheters and other technological advancements involved

90 transcatheter intervention using large-bore catheters and was associated with a statistically signif

91 one recent surgery, 73% had a central venous catheter, and 41% were receiving systemic antifungal the

92 . mirabilis crystalline biofilm formation on catheters, and increase the time taken for catheters to

93 Catheter angiography appears to be unhelpful, suggesting

94 on, and therefore without telescopic plugged catheter, antibiotic treatment was continued for 7 days.

95 r optical near-infrared fluorescence imaging catheters are emerging to assess new biologic targets in

96 scatheter interventions that used large-bore catheters are frequent and associated with high mortalit

97 All clinical high-resolution multipolar catheters are of sufficient resolution to accurately det

98 INTRODUCTION: Single-use intermittent catheters are the norm in the UK although multi-use is c

99 ICE: This paper highlights that if multi-use catheters are to be successfully introduced into clinica

100 ic hemodialysis patients with central venous catheters as vascular access had their ScvO2 monitored d

101 Catheter associated urinary tract infection (CAUTI) is t

102 and Pseudomonas aeruginosa, respectively, in catheter-associated biofilms in vitro.

103 coccus aureus (MRSA) is an emerging cause of catheter-associated urinary tract infection (CAUTI), whi

104 When we focused on the risk of catheter-associated urinary tract infections (CAUTI) cau

105 tion of this probe in detecting the onset of catheter-associated urinary tract infections (CAUTIs) is

106 expanded these findings to a murine model of catheter-associated UTI (CAUTI), delineated the contribu

107 ive adult patients with a chronic indwelling catheter-associated UTI and sepsis hospitalized in medic

108 stitis (both uncomplicated and complicated), catheter-associated UTI, and asymptomatic bacteriuria in

109 rogrammed VA (UPVA) (tunneled or nontunneled catheters) at the initiation of HD.

110 Aortic valve replacement (surgical or catheter based) was performed more frequently (54.0% vs

111 Surgical and catheter-based cardiovascular procedures and adjunctive

112 Catheter-based interventions, not recorded before 1990,

113 ion of new surgical techniques by developing catheter-based interventions, with elimination of open h

114 ounger and more preterm patients, often with catheter-based interventions.

115 underwent 11,968 cardiac surgeries and 1,912 catheter-based interventions.

116 Clinical trials applying catheter-based radiofrequency renal denervation (RDN) de

117 ted follow-up studies examining surgical and catheter-based reinterventions in long-term survivors of

118 Long-term efficacy of catheter-based treatment of persistent atrial fibrillati

119 mes of transcatheter aortic and mitral valve catheter-based valve procedures in the United States.

120 We tested a novel, central line catheter-based, transvenous phrenic nerve pacing therapy

121 d to have arteriovenous fistulas rather than catheters because of significantly lower mortality rates

122 The impact of these drugs on catheter biofilm formation by other uropathogens (Escher

123 for efflux pump inhibitors (EPIs) to control catheter blockage.

124 liver lobe resection combined with arterial catheter blood withdrawal to achieve a sustained systoli

125 a novel linear irrigated multipolar ablation catheter capable of creating linear lesions with a singl

126 Both CRBSI and catheter colonization were the most commonly evaluated o

127 he detrimental consequences of polymicrobial catheter colonization, particularly by P. mirabilis and

128 For catheter colonization, significant decreases were shown

129 This study reports the first intravascular catheter combining intravascular ultrasound (IVUS) with

130 dside ultrasound reduced mean central venous catheter confirmation time by 58.3 minutes.

131 eter may provide important information about catheter contact, wall thickness, and ablation lesion fo

132 The linear catheter contained 7 irrigated electrodes spaced over 3.

133 tion using a novel linear irrigated ablation catheter; control animals underwent focal lesions in a l

134 f both multi-use and single use intermittent catheters could provide users with more flexible choices

135 n the epidemiologic association and positive catheter cultures for BCG in patients in whom mycobacter

136 total number of cultures and central venous catheter cultures, without an increase in rates of morta

137 initiate hemodialysis with a central venous catheter (CVC) and subsequently undergo placement of a n

138 ulation was 2.4 episodes/1000 central venous catheter (CVC) days [95% Poisson confidence limits (CLs)

139 The efficacy of antimicrobial central venous catheters (CVCs) remains questionable.

140 bidities (intravenous central lines, urinary catheters, diabetes mellitus, AIDS, end-stage renal dise

141 emonstrate the feasibility of imaging-guided catheter-directed delivery of endothelial cell therapy i

142 ts confirm the feasibility of imaging-guided catheter-directed endothelial cell therapy with an intra

143 a team can help determine which intervention-catheter-directed fibrinolysis, ultrasound-assisted thro

144 emic thrombolysis, surgical embolectomy, and catheter-directed therapy for submassive and massive PE

145 Pharmacomechanical catheter-directed thrombolysis (hereafter "pharmacomecha

146 rombosis, the addition of pharmacomechanical catheter-directed thrombolysis to anticoagulation did no

147 mortality observed in patients treated with catheters does not appear to be due to direct, access-re

148 nts): 227 patients (73.5%) underwent primary catheter drainage and 82 patients (26.5%) underwent prim

149 In this propensity-matched cohort, catheter drainage as first intervention for severe pancr

150 the clinical outcome of patients undergoing catheter drainage compared with relaparotomy as primary

151 First intervention for pancreatic fistula: catheter drainage or relaparotomy.

152 Primary catheter drainage was successful (ie, survival without r

153 re matched to 64 patients undergoing primary catheter drainage.

154 CI, 0.20-0.77) were also lower after primary catheter drainage.

155 In these three cases, major catheter dysfunction occurred before clotting within the

156 ed in place until active labour started, the catheter fell out, or 12 h had elapsed.

157 afety of an irrigated, contact force-sensing catheter for ablation of drug refractory, symptomatic pa

158 50 kg Yorkshire swine with a femoral artery catheter for blood pressure measurement and a pulmonary

159 pressure measurement and a pulmonary artery catheter for bolus thermodilution.

160 line at room temperature through a dedicated catheter for coronary thermodilution induces steady-stat

161 preclinical and clinical performance of this catheter for pulmonary vein (PV) isolation.

162 uction analysis of the THERMOCOOL SMARTTOUCH Catheter for the Treatment of Symptomatic Paroxysmal Atr

163 g) to male rats fitted with intravenous (iv) catheters for repeated blood sampling.

164 dida spp. adhere to medical devices, such as catheters, forming drug-tolerant biofilms that resist ki

165 of Aortic Valve Bioprostheses Established by Catheter [FRANCE TAVI]; NCT01777828).

166 vestigate external photon beam radiation for catheter-free ablation of the atrioventricular junction

167 We combined these techniques to perform catheter-free, electrophysiology-guided, noninvasive car

168 m crystalline biofilms on indwelling urinary catheters, frequently leading to polymicrobial infection

169 Consistent with this model, analysis of catheters from patients with S. aureus-positive cultures

170 n in the misoprostol group than in the Foley catheter group (172 [57.0%] vs 141 [47.0%] women; absolu

171 significantly lower mortality rates than the catheter group had over 58 months (hazard ratio, 0.66; 9

172 including two stillbirths (both in the Foley catheter group) and eight neonatal deaths (n=5 in the mi

173 n the misoprostol group and n=3 in the Foley catheter group); and five of neonatal morbidity, compris

174 with 32%, 46%, and 62%, respectively, in the catheter group.

175 n were low in both the misoprostol and Foley catheter groups (two [0.7%] vs one [0.3%] cases; absolut

176 Patients using catheters had greater mortality than those with a PVA (l

177 analysis showed that initiation of HD with a catheter (hazard ratio, 5.90; 95%, confidence interval,

178 NFUS catheter imaging reliably assesses electrode-tissue cont

179 male Fisher rats by inflating a 4.0F Fogarty catheter in the epidural space.

180 rom polydioxanone suture were deployed via a catheter in the IVC of 11 swine.

181 Telescopic plugged catheter in these 92 patients showed bacterial aspiratio

182 s and cultures collected from central venous catheters in critically ill children and to examine the

183 diography for confirmation of central venous catheters in sufficient detail to reconstruct 2 x 2 cont

184 The role of balloon catheters in this patient population remains ill defined

185 igned open-irrigated radiofrequency ablation catheter incorporating 4 ultrasound transducers.

186 ection when used in a CLS rat central venous catheter infection model.

187 enation cannula infection, and one pulmonary-catheter infection.

188 s, in the treatment of S. aureus intravenous catheter infections.

189 Of the catheters inserted, 188 (38%) were antibiotic-impregnate

190 from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with establish

191 historic controls who had unassisted central catheter insertion at the same sites.

192 me ultrasound guidance during central venous catheter insertion has become a standard of care, postin

193 le-operator ultrasound-guided central venous catheter insertion is effective in verifying proper tip

194 Selection of central venous catheter insertion site in ICU patients could help reduc

195 use of ultrasound can reduce central venous catheter insertion to use time, exposure to radiation, a

196 Prolonged dwell time and catheter insertion under emergent conditions increased r

197 trasound-guided, right-sided, central venous catheter insertion verifies proper placement and shorten

198 costal transthoracic echocardiography during catheter insertion.

199 , even when patients are hemodialyzed with a catheter instead, may explain at least two thirds of the

200 e included additional cardiac surgery (32%), catheter intervention (62%), arrhythmia treatment (32%),

201 Catheter intervention for anatomic indications was assoc

202 Catheter intervention for physiological indications was

203 olgus monkeys after insertion of a roughened catheter into either the vena cava or the aorta.

204 otor core although the low-resolution basket catheter is prone to false detections and may incorrectl

205 ies, and the descending abdominal aorta) and catheters (jugular vein, peritoneal cavity, and distal a

206 e of pleural fluid via an indwelling pleural catheter led to a higher rate of autopleurodesis and fas

207 The rate of peripherally inserted central catheter line complications was 3.2% in the intravenous

208 dent on HPS, the taurolidine-citrate-heparin catheter lock demonstrates a clinically substantial and

209 the efficacy and safety of the antimicrobial catheter lock solution, taurolidine-citrate-heparin, com

210 ective antibiofilm treatment when applied as catheter lock solutions (CLSs) against S. aureus biofilm

211 and sonographic imaging technique to detect catheter malposition and procedure-related pneumothorax.

212 with a pooled sensitivity and specificity of catheter malposition by ultrasound of 0.82 (0.77-0.86) a

213 d positive and negative likelihood ratios of catheter malposition by ultrasound were 31.12 (14.72-65.

214 When a central venous catheter malposition exists, bedside ultrasound will ide

215 nerve pacing using a novel electrode-bearing catheter may provide a means to prevent diaphragm atroph

216 hrough transducers in the tip of an ablation catheter may provide important information about cathete

217 lation plus pharmacomechanical thrombolysis (catheter-mediated or device-mediated intrathrombus deliv

218 e conventional high-frequency, side-looking, catheter-mounted transducers.

219 Electric signals recorded on the ablation catheter not coincident with atrial or ventricular depol

220 dy was performed using a 64-electrode basket catheter on the left ventricle endocardium and 54 6-elec

221 he authors sought to show the feasibility of catheter-only, closed-chest, large-vessel anastomosis (s

222 timicrobial impregnation with nonimpregnated catheters or catheters with another impregnation were in

223 less likely than individuals with indwelling catheters or grafts to be hospitalized (odds ratios, 0.7

224 dialysis patients is due to the avoidance of catheters or if healthier patients are simply more likel

225 pinal fluid collection via indwelling lumbar catheter over 36 to 48 hours before, during, and after i

226 an increase in the rate of pulmonary artery catheter (PAC) use in heart failure admissions.

227 ce may be required to establish that a mixed catheter package is equivalent to single use only, parti

228 le overuse, of peripherally inserted central catheters (PICCs).

229 Using the DiamondTemp (DT) catheter, pigs (n = 6) underwent discrete atrial ablatio

230 er after a fistula placed first failed, or a catheter placed first (n=90,517; reference group).

231 (8 patients) or through a balloon occlusion catheter placed through the sheath (10 patients) simulta

232 d <6 months) undergoing cardiac surgery with catheter placement for PD were approached for inclusion.

233 As shown previously, catheter placement induced an inflammatory response resu

234 Fifteen studies with 1,553 central venous catheter placements were identified with a pooled sensit

235 ltrasound for confirmation of central venous catheter position and exclusion of pneumothorax compared

236 de ultrasound confirmation of central venous catheter position.

237 o testing was performed in 19 dogs with NFUS catheters positioned in 4 chambers.

238 outcomes included the accuracy of confirming catheter positioning and detecting a pneumothorax.

239 hen used to accurately assess central venous catheter positioning and screen for pneumothorax.

240 of pneumothorax and accurate central venous catheter positioning.

241 rial flow to the tumor and through selective catheter positioning.

242 Nonprogrammed VA with a catheter predicted all-cause mortality among patients wi

243 Short-term peripheral venous catheters (PVCs) are commonly used in healthcare setting

244 he high frequency of hospitalizations due to catheter-related bacteremia.

245 ections, five blood stream infections, three catheter-related blood stream infections, two colitis, o

246 y outcomes were clinically diagnosed sepsis, catheter-related bloodstream infection (CRBSI), and all-

247 Current evidence on catheter-related bloodstream infection femoral risk, com

248 Catheter-related bloodstream infection risk was comparab

249 for baseline characteristics were excluded, catheter-related bloodstream infection risk was comparab

250 ular and subclavian may, similarly, decrease catheter-related bloodstream infection risk, when compar

251 are receiving home parenteral support (HPS), catheter-related bloodstream infections (CRBSIs) inflict

252 3% and 23% of nosocomial BSIs and nosocomial catheter-related BSIs, respectively.

253 Catheter-related infection was considered the mechanism

254 antimicrobial CVC impregnations in reducing catheter-related infections in adults.

255 sibility of TB due to nosocomially acquired, catheter-related infections with M. bovis-BCG in patient

256 rtion site in ICU patients could help reduce catheter-related infections.

257 The catheter remained in place until active labour started,

258 regression analysis, only early intravenous catheter removal (on day 2) [odds ratio: 0.390; 95% conf

259 peripheral intravenous and pulmonary artery catheter, respectively, after zeroing at the phlebostati

260 ern, an irrigated multipolar linear ablation catheter safely delivers contiguous endocardial or epica

261 (The CASABLANCA Study: Catheter Sampled Blood Archive in Cardiovascular Disease

262 drome routinely underwent telescopic plugged catheter sampling during bronchoscopy before starting pr

263 otic therapy when routine telescopic plugged catheter sampling recovered no microorganisms was nearly

264 is diagnosis confirmed by telescopic plugged catheter sampling.

265 This catheter shows promise for decreasing ventricular tachyc

266 aximum of 12 doses) or a transcervical Foley catheter (silicone, size 18 F with 30 mL balloon).

267 source, rotary joint assembly, 1 mm IVPA-US catheter size, differentiated A-line strategy, and real-

268 patients underwent PV isolation with the DT catheter (study group); patients were planned for PV rem

269 professionals based in the UK who prescribe catheters, teach intermittent catheterisation or manage

270 -654(renal elimination) were conducted using catheter techniques and intravital microscopy in animals

271 Progress in catheter technology did not occur in isolation, and the

272 crystalline biofilms on indwelling urethral catheters that block urine flow and lead to serious clin

273 ary outcome was the correct placement of the catheter tip determined by postprocedural chest radiogra

274 the gold standard to confirm central venous catheter tip position and rule out associated lung compl

275 Chest radiograph approximated accurate catheter tip position in 136 of 137 patients (99.3%).

276 n catheters, and increase the time taken for catheters to block.

277 d the ability of clinically used endocardial catheters to identify AF mechanisms using clinically rec

278 o identify subphenotypes in FACTT (Fluid and Catheter Treatment Trial; n = 1,000).

279 There was no association between catheter type or tunnelling distance and ERI.

280 ant difference in ERI risk between different catheter types.

281 Urinary catheter use is prevalent in health care settings, and p

282 must be acceptable and safe for intermittent catheter users.

283 The median time from end of the procedure to catheter utilization after chest radiography approval wa

284 ng proper tip placement and shortens time to catheter utilization.

285 rifies proper placement and shortens time to catheter utilization.

286 led irrigated ablation, a novel irrigated RF catheter was designed with a diamond-embedded tip (for r

287 A catheter was inserted into the right carotid artery of m

288 After catheterization, a transvenous pacing catheter was placed and adenosine was given following a

289 an series, diaphragm pacing with a temporary catheter was safe and effectively contributed to ventila

290 modulation (FIRM) with an endocardial basket catheter was used in all cases.

291 rodes and the BP waves recorded with carotid catheters were ensemble averaged relative to the R-peaks

292 Sixty studies with 17255 catheters were included.

293 n, and presence of central venous or urinary catheters were independently associated with HAIs.

294 A total of 495 EVD catheters were inserted into 452 patients with EVDs rema

295 The catheters were sealed with microinjection ports and then

296 A 9.5-Fr central venous catheter with 19 embedded electrodes was placed via Seld

297 A 3.7 Fr catheter with a fiber-optic channel was constructed base

298 Accurate positioning of central venous catheter with ultrasound was then confirmed in 121 of 12

299 mpregnation with nonimpregnated catheters or catheters with another impregnation were included.

300 calization of Fg, which was deposited on the catheter, with S. aureus Clumping Factors A and B (ClfA